Manhattan Vision Screening and Follow-up Study in Vulnerable Populations
SIGHT Studies at Columbia University
Enrollment Status (as of October 2022)
Lisa A. Hark, PHD, MBA, RD
Professor of Ophthalmic Sciences (Ophthalmology)
Vagelos College of Physicians and Surgeons
Edward S. Harkness Eye Institute
Columbia University Irving Medical Center
Innovative Vision Screening Model in Housing Buildings to Improve Early Detection of Glaucoma, Vision Impairment, Diabetic Retinopathy, and Cataracts
With the support of government, community, University, and industry partners, Dr. Lisa Hark, principal investigator, has designed the Manhattan Vision Screening and Follow-up Study in Vulnerable Populations, a cluster-randomized controlled trial, to identify and implement innovative strategies to engage populations most at risk, most vulnerable, and least likely to have access to eye care. The study population is comprised of disadvantaged men and women ≥40 years old of diverse race/ethnicity (primarily African American and Hispanic/Latino), with high rates of inadequate eye care, living in affordable housing buildings in New York City.
Vision Screening Conducted in Housing Building Includes:
- Ocular, medical, and family history
- Visual acuity check (Snellen chart)
- Eye pressure measurements
- Retina/optic nerve photography
- Falls risk and STEADI checklist
- Quality-of-Life survey
- Satisfaction surveys
For More Information
Community-Based Research | Columbia Ophthalmology
SIGHT Studies at Columbia University: Manhattan Vision Screening Follow-up Study in Vulnerable Populations Overview. The Manhattan Vision Screening and Follow-up Study in Vulnerable Populations, is a community-based to identify and implement innovative strategies to engage populations who need access to eye care.
Volk Optical, Inc.
Warby Parker Eyeglasses